Surgery
-
DEBATE: Surgical options in patients with diffuse (Grade 4 Yerdel) PVT: i) Liver transplant with inflow from vessels of all types and sizes is possible ii) Multi-Visceral Transplant is the best option iii) Discussion
For ILTS members only, please join now or renew your membership.
- Surgery ∙
- Rodrigo Vianna ∙
- 2019 ILTS Toronto ∙ Lecture ∙ June 10, 2019
-
ERAS for Liver Transplantation
For ILTS members only, please join now or renew your membership.
- Hepatology and 1 more ∙
- Stuart Mccluskey ∙
- 2019 ILTS Toronto ∙ Lecture ∙ June 10, 2019
-
Acute but different – key management decisions in ACLF vs. ALF
For ILTS members only, please join now or renew your membership.
- Anes/CCM and 2 more ∙
- Henrik Petrowsky ∙
- 2019 ILTS Toronto ∙ Lecture ∙ June 10, 2019
-
An evidence based review of TEG/ROTEM guided coagulation management
For ILTS members only, please join now or renew your membership.
- Anes/CCM and 1 more ∙
- Antoni Sabate ∙
- 2019 ILTS Toronto ∙ Lecture ∙ June 10, 2019
-
Best of Surgery
For ILTS members only, please join now or renew your membership.
- Surgery ∙
- John Fung ∙
- 2019 ILTS Toronto ∙ Lecture ∙ June 10, 2019
-
Biomarker for tolerance – who can have immunosuppression withdrawn?
For ILTS members only, please join now or renew your membership.
- Hepatology and 1 more ∙
- Nazia Selzner ∙
- 2019 ILTS Toronto ∙ Lecture ∙ June 10, 2019
-
Cirrhotic Cardiomyopathy
For ILTS members only, please join now or renew your membership.
- Anes/CCM and 2 more ∙
- Manhal Izzy ∙
- 2019 ILTS Toronto ∙ Lecture ∙ June 10, 2019
-
Vanguard Webinar – April 2019
For ILTS members only, please join now or renew your membership.
- Anes/CCM and 2 more ∙
- Blayne Amir Sayed and 2 others ∙
- Vanguard Webinars ∙ Webinar ∙ April 1, 2019
-
Vanguard Webinar – January 2019
For ILTS members only, please join now or renew your membership.
- Anes/CCM and 15 more ∙
- Gi Won Song and 3 others ∙
- Vanguard Webinars ∙ Webinar ∙ January 1, 2019
-
Vanguard Report: AKI, DCD & Outcomes, Late-breaking Abstracts
For ILTS members only, please join now or renew your membership.
- Anes/CCM and 13 more ∙
- Kalisvaart M ∙
- 2018 ELITA & LICAGE Lisbon ∙ Literature ∙ June 12, 2018
-
Vanguard Report: Translational Science, Outcomes, Viral Hepatitis
For ILTS members only, please join now or renew your membership.
- Anes/CCM and 12 more ∙
- Bhat M ∙
- 2018 ELITA & LICAGE Lisbon ∙ Literature ∙ June 12, 2018
-
Vanguard Report: Donor & Recipient Selection, ALF, Late-breaking Abstracts
For ILTS members only, please join now or renew your membership.
- Acute liver failure and 9 more ∙
- Kabacam G ∙
- 2018 ELITA & LICAGE Lisbon ∙ Literature ∙ June 12, 2018
-
Vanguard Report: Marginal Candidate, Viral Hepatitis, Immunosuppression
For ILTS members only, please join now or renew your membership.
- Acute liver failure and 13 more ∙
- de Martin E ∙
- 2018 ELITA & LICAGE Lisbon ∙ Literature ∙ June 12, 2018
-
Vanguard Report: NAS in DCD, Biliary Injury & Graft Fibrosis
For ILTS members only, please join now or renew your membership.
- Biliary complications and 5 more ∙
- Hessheimer A ∙
- 2018 ELITA & LICAGE Lisbon ∙ Literature ∙ June 12, 2018
-
Vanguard Report: Rising Star Abstracts, PSC, Limits in Oncology
For ILTS members only, please join now or renew your membership.
- Anes/CCM and 8 more ∙
- Contreras A ∙
- 2018 ELITA & LICAGE Lisbon ∙ Literature ∙ June 12, 2018
-
Liver transplantation for malignancies: LT for HCC – modelling the criteria
For ILTS members only, please join now or renew your membership.
- Hepatology and 1 more ∙
- Christian Toso ∙
- 2017 Joint International Congress ∙ Lecture ∙ December 13, 2017
-
Liver transplantation for malignancies: Neuroendocrine tumors and LT
For ILTS members only, please join now or renew your membership.
- Hepatology and 1 more ∙
- Vincenzo Mazzaferro ∙
- 2017 Joint International Congress ∙ Lecture ∙ December 13, 2017
-
HBV and HCV: HCV/HIV pre and posttransplant management
For ILTS members only, please join now or renew your membership.
- Hepatology and 1 more ∙
- Jean-charles Duclos-vallee ∙
- 2017 Joint International Congress ∙ Lecture ∙ December 13, 2017
-
HBV and HCV: New ELITA guidelines for prevention of HBV recurrence
For ILTS members only, please join now or renew your membership.
- Hepatology and 1 more ∙
- Christophe Duvoux ∙
- 2017 Joint International Congress ∙ Lecture ∙ December 13, 2017
-
HBV and HCV: Remaining challenges of HCV in liver transplant recipients
For ILTS members only, please join now or renew your membership.
- Hepatology and 1 more ∙
- Norah Terrault ∙
- 2017 Joint International Congress ∙ Lecture ∙ December 13, 2017
-
Fulminant liver failure: Transplant options for FHF
For ILTS members only, please join now or renew your membership.
- Hepatology and 1 more ∙
- Yaman Tokat ∙
- 2017 Joint International Congress ∙ Lecture ∙ December 13, 2017
-
Fulminant liver failure: Managing the brain
For ILTS members only, please join now or renew your membership.
- Hepatology and 1 more ∙
- William Bernal ∙
- 2017 Joint International Congress ∙ Lecture ∙ December 13, 2017
-
Fulminant liver failure: Intraoperative challenges
For ILTS members only, please join now or renew your membership.
- Hepatology and 1 more ∙
- James Findlay ∙
- 2017 Joint International Congress ∙ Lecture ∙ December 13, 2017
-
Fulminant liver failure: ICU support: beyond the brain
For ILTS members only, please join now or renew your membership.
- Hepatology and 1 more ∙
- Catherine Paugam-burtz ∙
- 2017 Joint International Congress ∙ Lecture ∙ December 13, 2017
-
Mastering Viral Infections in Liver Transplantation: Clinical case presentation: “De novo autoimmune hepatitis recurrence after IFN-free antiviral therapy for hepatitis C after liver transplantation”
For ILTS members only, please join now or renew your membership.
- Hepatology and 1 more ∙
- Alberto Zanetto ∙
- 2017 Joint International Congress ∙ Lecture ∙ December 13, 2017
-
Liver machine perfusion: Markers of early allograft failure
For ILTS members only, please join now or renew your membership.
- Hepatology and 1 more ∙
- Kim Olthoff ∙
- 2017 Joint International Congress ∙ Lecture ∙ December 13, 2017